Trellus Health (TRLS) Share Price, News & Analysis

Company Overview

Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers TrellusElevate, a proprietary HIPAA-compliant technology platform to coordinate and deliver personalized care remotely through telemedicine. Its platform provides patients with access to a care team, educational content resources, and remote monitoring capabilities for the treatment of inflammatory bowel diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis. The company was founded in 2020 and is headquartered in White Plains, New York.

Key Stats

• Today's Range: 0.65 to 0.70
• 50-Day Range: 0.63 to 1.41
• 52-Week Range: 0.60 to 7.38
• Volume: 23,373 shs
• Average Volume: 698,960 shs
• Market Capitalization: £1.05 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

TRLS Stock Analysis - Frequently Asked Questions

How have TRLS shares performed this year?

Trellus Health's stock was trading at GBX 3.25 at the beginning of the year. Since then, TRLS shares have decreased by 80.0% and is now trading at GBX 0.65.
View the best growth stocks for 2024 here.

How do I buy shares of Trellus Health?

Shares of TRLS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of Trellus Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Trellus Health investors own include Bird Global (BRDS), boohoo group (BOO), Baron Oil (BOIL), Bidstack Group (BIDS), Fiinu (BANK), ARM (ARM) and Argo Blockchain (ARB).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Health Information Services
• Sub-Industry: N/A
• Current Symbol: LON:TRLS
• CUSIP: N/A
• CIK: N/A
• Web: www.trellushealth.com
• Phone: 800-866-4165
• Fax: N/A
• Employees: 31
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX (0.03)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: £-6,660,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -35.08%
• Return on Assets: -22.76%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 14.14
• Quick Ratio: 17.11

Sales & Book Value

• Annual Sales: £35,000.00
• Price / Sales: 32.30
• Cash Flow: GBX 0.92 per share
• Price / Cash Flow: 0.76
• Book Value: GBX 10 per share
• Price / Book: 0.07

Miscellaneous

• Outstanding Shares: 161,510,000
• Free Float: N/A
• Market Cap: £1.13 million
• Optionable: Not Optionable
• Beta: 0.01